Federal Circuit Refuses Rehearing Of Homocysteine Assay Patent Case

Law360, New York (August 6, 2004, 12:00 AM EDT) -- The U.S. Court of Appeals for the Federal Circuit has denied LabCorp's petition for a rehearing of a lawsuit brought by Competitive Technologies on behalf of two university clients over a homocysteine assay patent.

"CTT and its clients have successfully prevailed in multiple venues in this important case. We applaud the Court of Appeals for the Federal Circuit’s decision to reaffirm the lower court's decision and will work with LabCorp for a final licensing agreement,” John B. Nano, CTT's President and CEO, said in a statement....
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.